IA
RCEL icon

IFP Advisors’s Avita Medical RCEL Stock Holding History

IFP Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69K Buy
409
+377
+1,178% +$1.63K ﹤0.01% 4308
2026
Q1 		$118 Buy
32
+2
+7% +$8 ﹤0.01% 4710
2025
Q4 		$104 Sell
30
-3
-9% -$12 ﹤0.01% 4583
2025
Q3 		$169 Buy
33
+31
+1,550% +$162 ﹤0.01% 4427
2025
Q2 		$11 Sell
2
-2
-50% -$15 ﹤0.01% 4871
2025
Q1 		$33 Hold
4
– – ﹤0.01% 4098
2024
Q4 		$51 Buy
+4
New +$47 ﹤0.01% 4253
2023
Q3 		– Sell
-183
Closed -$3.11K – 3504
2023
Q2 		$3.11K Buy
+183
New +$2.69K ﹤0.01% 2717
2023
Q1 		– Sell
-2,475
Closed -$74K – 4216
2022
Q4 		$74K Sell
2,475
-255
-9% -$1.53K ﹤0.01% 1957
2022
Q3 		$81K Hold
2,730
– – ﹤0.01% 2006
2022
Q2 		$81K Hold
2,730
– – ﹤0.01% 1827
2022
Q1 		$81K Buy
+2,730
New +$25.2K ﹤0.01% 1827

Other funds holding RCEL

TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

IFP Advisors's RCEL Position: Q2 2026 in Review

IFP Advisors increased its Avita Medical (RCEL) stake by 1,178% in Q2 2026, buying an estimated $1.63K and bringing the position to 409 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #4308.

IFP Advisors first reported a position in RCEL in Q1 2022 and has held it in 12 quarters since. The position peaked at $81K in Q3 2022. 12 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • IFP Advisors held 409 shares of Avita Medical worth $1.69K as of Q2 2026.
  • IFP Advisors bought 377 Avita Medical shares in Q2 2026, an estimated $1.63K.
  • Avita Medical made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4308 holding.
  • IFP Advisors first reported a position in Avita Medical in Q1 2022 and has held it in 12 quarters since.
  • IFP Advisors's Avita Medical position peaked at $81K in Q3 2022.
  • 12 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.